期刊文献+

血清microRNA-25对脓毒症患者病情严重程度及预后的评估价值 被引量:5

Evaluation value of serum microRNA-25 on severity and prognosis of sepsis patients
原文传递
导出
摘要 目的:探究血清microRNA-25对评估脓毒症患者病情严重程度及预后的价值,分析影响脓毒症患者预后的危险因素。方法:选取82例脓毒症患者作为研究对象,根据患者病情严重程度分为脓毒症组及脓毒性休克组,30例健康体检者作为对照组。采用实时荧光定量检测方法(RT-PCR)检测血清microRNA-25表达量。记录入组患者的一般资料(性别、年龄、感染部位)和相关指标(WBC、CRP、PCT、D-D、Lac、Cys-C、SOFA评分、APACHEⅡ评分)。根据28 d预后情况分为存活组和死亡组。筛选影响脓毒症患者预后的独立危险因素,评估死亡独立危险因素对脓毒症患者死亡的预测效果。结果:①脓毒症组和脓毒性休克组间、存活组和死亡组间的性别、年龄、感染部位等差异均无统计学意义(P>0.05)。②与脓毒症组相比,脓毒性休克组患者的PCT、D-D、Lac、Cys-C、SOFA评分及APACHEⅡ评分均升高(P<0.05);③脓毒性休克组患者血清microRNA-25表达量低于脓毒症组(P<0.05);④与存活组相比,死亡组患者的PCT、D-D、Lac、Cys-C、SOFA评分及APACHEⅡ评分显著升高(P<0.05);死亡组患者microRNA-25明显低于存活组,差异有统计学意义(P<0.05)。⑤PCT、D-D、Lac、Cys-C、microRNA-25、SOFA评分、APACHEⅡ评分是脓毒症患者28 d死亡危险因素,且Lac、Cys-C、microRNA-25、SOFA评分是脓毒症患者28 d死亡的独立危险因素。结论:血清microRNA-25可作为评估脓毒症患者病情严重程度及判断预后的生物标志物;Lac、Cys-C、microRNA-25、SOFA评分是脓毒症患者28 d死亡的独立危险因素。 Objective:To explore the value of serum microRNA-25 in evaluating the severity and prognosis of sepsis patients,and analyze the risk factors affecting the prognosis of sepsis patients.Method:Eighty-two patients with sepsis were selected as the research object,and the patients were divided into sepsis group and septic shock group according to the severity of the disease.Thirty healthy subjects were used as the control group.Real-time fluorescence quantitative detection method(RT-PCR)was used to detect the expression of microRNA-25 in serum.Record the general information(sex,age,infection site)and related indicators(WBC,CRP,PCT,D-D,Lac,Cys-C,SOFA score,APACHEⅡscore)of the enrolled patients.According to the prognosis of 28 days,they were divided into survival group and death group.The independent risk factors that can affect the prognosis of sepsis patients were screened,and the predictive effect of independent risk factors for death of sepsis patients was assessed.Result:①The differences in age,gender and infection site were not statistically significant between sepsis group and septic shock group,as well as survival group and death group.②Compared with sepsis group,PCT,D-D,Lac,Cys-C,SOFA and APACHEⅡscores in septic shock group were all increased(P<0.05).③The expression of serum microRNA-25 in septic shock group was lower than that in sepsis group(P<0.05).④Compared with the survival group,PCT,D-D,Lac,Cys-C,SOFA and APACHEⅡscores of the patients in the death group were significantly higher(P<0.05);microRNA-25 in the dead group was significantly lower than that in the surviving group(P<0.05).⑤PCT,D-D,Lac,Cys-C,microRNA-25,SOFA scores and APACHEⅡscores are risk factors for 28-day death of sepsis patients,and Lac,Cys-C,microRNA-25 and SOFA scores are independent risk factors for 28-day death of sepsis patients.Conclusion:Serum microRNA-25 can be used as a biomarker to evaluate the severity and prognosis of sepsis patients.Lac,Cys-C,microRNA-25 and SOFA scores are independent risk factors for 28-day death in sepsis patients.
作者 王静波 燕宪亮 王厚清 许铁 WANG Jingbo;YAN Xianliang;WANG Houqing;XU Tie(Emergency Center of the Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu,221002,China)
出处 《临床急诊杂志》 CAS 2020年第6期493-498,共6页 Journal of Clinical Emergency
关键词 脓毒症 脓毒性休克 microRNA-25 sepsis septic shock microRNA-25
  • 相关文献

参考文献8

二级参考文献30

  • 1林洪远,管向东,周立新,艾宇航,王可富.乌司他丁、α1胸腺肽联合治疗严重脓毒症——一种新的免疫调理治疗方法的临床研究[J].中华医学杂志,2007,87(7):451-457. 被引量:100
  • 2Singer M, Deutschman CS, Seymour CW, et al. The Third In- ternational Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)[J]. JAMA,2016,315(8):801-810. DOI:I0.1001/ jama. 2016.0287.
  • 3Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a new definition and assessing new clinical criteria for septic shock : for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA,2016,315(8):775-787. DOI: 10.1001/jama.2016.0289.
  • 4Seymour CW, Liu VX, lwashyna TJ, et al. Assessment of clln- ical criteria for sepsis: for the Third International Consensus Def- initions tbr Sepsis and Septic Shock (Sepsis-3) [ J]. JAMA, 2016,315(8) :762-774.D01: 10.1001/jama.2016.0288.
  • 5Bone RC, Balk RA, Cerra FB, et al. American Chest Physicians/Society of Critical Care Medicine Conference: definitions for sepsis and organ failure lines for the use of innovative therapies in sepsis [ J ] Med, 1992,20(6) : 864-874.
  • 6College of Consensus and guide- Crit Care Levy MM, Fink MP, Marshall JC, et al. International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS In- ternational Sepsis Definitions Conference [ J]. Intensive Care Med, 2003,29 (4) : 530-538.
  • 7Kaukonen KM, Bailey M, Pilcher D, et al. Systemic inflam- matory response syndrome criteria in defining severe sepsis [ J ]. N Engl J Med, 2015,372(17) : 1629-1638. DOI: 10. 1056/NEJMoa- 1415236.
  • 8Vincent JL, Mira JP, Antonelli M. Sepsis: older and newer concepts. Lancet Respir Med, 2016, 4 ( 3 ) : 237-240. DOI: 10. 1016/$2213-2600( 15)00522-6.
  • 9Mouncey PR, Osborn TM, Power GS, et al. Trial of early, goal-directed resuscitation for septic shock [ J ]. N Engl J Med,2015,372(14) : 1301-1311.DOI : 10.1056/NEJMoa1500896.
  • 10ARISE Investigators, ANZICS Clinieal Trials Group, Peake SL, et al. Goal-directed resuscitation for patients with early septic shock[ J]. N Engl J Med,2014,371 (16) : 1496-1506.DOI: 10. 1056/NEJMoa1404380.

共引文献308

同被引文献55

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部